SkyOak Wealth LLC Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

SkyOak Wealth LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,090 shares of the healthcare conglomerate’s stock after buying an additional 139 shares during the quarter. SkyOak Wealth LLC’s holdings in UnitedHealth Group were worth $1,563,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. McAdam LLC lifted its stake in shares of UnitedHealth Group by 29.1% in the 4th quarter. McAdam LLC now owns 980 shares of the healthcare conglomerate’s stock worth $496,000 after acquiring an additional 221 shares during the period. Sutton Place Investors LLC lifted its position in UnitedHealth Group by 5.2% in the fourth quarter. Sutton Place Investors LLC now owns 939 shares of the healthcare conglomerate’s stock valued at $475,000 after purchasing an additional 46 shares during the period. Jacobsen Capital Management increased its position in UnitedHealth Group by 2.0% during the 4th quarter. Jacobsen Capital Management now owns 1,537 shares of the healthcare conglomerate’s stock worth $778,000 after purchasing an additional 30 shares during the period. Greenleaf Trust lifted its holdings in shares of UnitedHealth Group by 1.1% in the 4th quarter. Greenleaf Trust now owns 23,242 shares of the healthcare conglomerate’s stock valued at $11,757,000 after buying an additional 261 shares during the period. Finally, Golden State Equity Partners grew its holdings in UnitedHealth Group by 405.1% during the fourth quarter. Golden State Equity Partners now owns 3,359 shares of the healthcare conglomerate’s stock worth $1,699,000 after acquiring an additional 2,694 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.6 %

Shares of UnitedHealth Group stock opened at $542.30 on Friday. The firm has a market cap of $499.07 billion, a PE ratio of 34.99, a P/E/G ratio of 1.46 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The business’s fifty day moving average is $536.17 and its two-hundred day moving average is $565.26.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Incorporated will post 29.64 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Bank of America decreased their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.